Table 5.
Depression, univariate and multivariate logistic regression analysis
| Variables | Univariate |
Multivariate |
||||
|---|---|---|---|---|---|---|
| p value | OR | 95% CI | p value | OR | 95% CI | |
| Age | 0.6270 | 1.006 | 0.981‒1.032 | |||
| Sex (men) | 0.0110 | 0.552 | 0.348‒0.874 | 0.0003 | 0.383 | 0.228‒0.644 |
| HY stage | 0.0180 | 1.489 | 1.071‒2.071 | |||
| UPDRS II | < 0.0001 | 1.133 | 1.085‒1.183 | < 0.0001 | 1.129 | 1.079‒1.182 |
| UPDRS III | 0.0170 | 1.026 | 1.005‒1.047 | |||
| Motor fluctuation | 0.3230 | 1.290 | 0.779‒2.139 | |||
| Dyskinesia | 0.1880 | 1.371 | 0.857‒2.194 | |||
| ESS | < 0.0001 | 1.099 | 1.054‒1.145 | 0.0002 | 1.092 | 1.043‒1.143 |
| Laterality | ||||||
| Left | 0.9620 | 1.014 | 0.571‒1.803 | |||
| Symmetric | 0.2580 | 1.372 | 0.793‒2.373 | |||
| Total LEDD | 0.5460 | 1.000 | 1.000‒1.001 | |||
| Levodopa | 0.7180 | 1.000 | 0.999‒1.001 | |||
| Ropinirole | 0.5850 | 1.011 | 0.971‒1.053 | |||
HY stage: Hoehn and Yahr stage, UPDRS: Unified Parkinson’s Disease Rating Scale, ESS: Epworth Sleepiness Scale, LEDD: levodopa equivalent daily dose, OR: odds ratio, CI: confidence interval.